{"id":"W2021777913","doi":"10.1016/j.ctrv.2011.12.002","title":"Controlling angiogenesis in breast cancer: A systematic review of anti-angiogenic trials","year":2012,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":105,"is_retracted":false,"has_abstract":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Queen Elizabeth II Health Sciences Centre; BC Cancer Agency; Sunnybrook Health Science Centre; Health Sciences Centre; MacEwan University","funders":"Alberta Health Services","keywords":"Medicine; Sunitinib; Pazopanib; Bevacizumab; Oncology; Clinical trial; Sorafenib; Breast cancer; Internal medicine; Adverse effect; Randomized controlled trial; Chemotherapy; Cancer; Angiogenesis","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0024148,0.001121173,0.01286591,0.0002074342,0.00005337939,0.0000192536,0.0005247052,0.0004755603,0.0003423117],"category_scores_gemma":[0.0001074541,0.000684555,0.005695864,0.0006028427,0.00006907328,0.00000946223,0.00008880011,0.00008831783,0.00003866152],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005679441,"about_ca_system_score_gemma":0.0007910438,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000295173,"about_ca_topic_score_gemma":0.00008166065,"domain_scores_codex":[0.9923657,0.001952518,0.003929651,0.0008682599,0.0002559637,0.0006279004],"domain_scores_gemma":[0.9947215,0.0001325728,0.003540783,0.00127162,0.0001396703,0.0001938657],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00001080379,0.0001272443,0.0001217686,0.6876527,0.001823209,0.000002407248,0.000006851561,7.939182e-7,0.00005817032,0.00000269041,0.0006189184,0.3095744],"study_design_scores_gemma":[0.0003485316,0.00004113007,0.000003455728,0.444518,0.01734582,0.00002498079,0.000001691109,2.189737e-7,0.00004714895,1.987586e-7,0.5372891,0.0003796603],"study_design_candidate":"systematic_review","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000007613772,0.9892347,0.00001480249,0.00004387232,0.0004347721,0.008667758,0.001537661,0.00001052007,0.00004830976],"genre_scores_gemma":[0.00001789791,0.9825887,0.00004859849,0.0002317714,0.0008968466,0.01531132,0.0004973341,0.0001281037,0.0002794114],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.5366702,"threshold_uncertainty_score":0.9995605,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.10315423392928,"score_gpt":0.3966961620687006,"score_spread":0.2935419281394205,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}